News & Updates

Many wasting disorders remain under-recognized and undertreated among older adults with cancer, and there exists a need to properly identify and manage these conditions, suggests a study.

Individuals with diets high in animal fat and protein and low in carbohydrates appear to be at heightened risk of hepatocellular carcinoma (HCC), according to a Singapore study.

Adjuvant treatment with mRNA-4157 and pembrolizumab led to sustained improvements in recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) at approximately 3 years in individuals with resected high-risk melanoma as opposed to pembrolizumab alone, according to the updated results of the phase II KEYNOTE-942 trial presented at ASCO 2024.

The combination regimen comprising sotorasib and panitumumab demonstrates a trend towards an improvement in overall survival (OS) compared with investigator’s choice of therapy among patients with chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC) who had progressed on systemic therapy, according to the OS analysis of the CodeBreak 300 trial presented at ASCO 2024.

Outcomes of allogeneic hematopoietic cell transplant (alloHCT) do not differ in patients who underwent either one or two sets of busulfan therapeutic drug monitoring (TDM) sampling, reports a study.

Identifying hypersensitivity reactions to anticancer chemotherapy and monoclonal antibodies may help clinicians improve management of patients with oncological diseases, suggests a study.